Guess where you can snag @workX_official before it rockets onto KuCoin markets.
04 Dec 2023, 12:30
🔍 Guess where you can snag @workX_official before it rockets onto KuCoin markets?
⏳ Less than 5 hours remain to join $WORK's FCFS round with a free Decubate base tier account:
Same news in other sources
2
04 Dec 2023, 12:45
Triall Insights 🔍
Biotech is on the rise.
Since 2021, 60% of novel therapies approved by the FDA are biotech products.
Moreover, global sales of biotech products have consistently increased since 2018, surpassing $466 billion in 2022.
Source: csdd.tufts.edu/impact-reports
🗣️ Help us spread the news:
#blockchainforhealth #TRL
Triall Insights. Biotech is on the rise. Since 2021, 60% of novel therapies approved by the FDA are biotech products.
Triall Insights 🔍
Biotech is on the rise.
Since 2021, 60% of novel therapies approved by the FDA are biotech products.
Moreover, global sales of biotech products have consistently increased since 2018, surpassing $466 billion in 2022.
Source: csdd.tufts.edu/impact-reports
🗣️ Help us spread the news:
https://x.com/triallofficial/status/1731655589191713253?s=20
#blockchainforhealth #TRL
04 Dec 2023, 12:45
Triall Insights 🔍
Biotech is on the rise.
Since 2021, 60% of novel therapies approved by the FDA are biotech products.
Moreover, global sales of biotech products have consistently increased since 2018, surpassing $466 billion in 2022.
Source: csdd.tufts.edu/impact-reports
🗣️ Help us spread the news:
#blockchainforhealth #TRL
Triall Insights. Biotech is on the rise. Since 2021, 60% of novel therapies approved by the FDA are biotech products.
Triall Insights 🔍
Biotech is on the rise.
Since 2021, 60% of novel therapies approved by the FDA are biotech products.
Moreover, global sales of biotech products have consistently increased since 2018, surpassing $466 billion in 2022.
Source: csdd.tufts.edu/impact-reports
🗣️ Help us spread the news:
https://x.com/triallofficial/status/1731655589191713253?s=20
#blockchainforhealth #TRL